519 related articles for article (PubMed ID: 37507803)
1. Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy.
Zheng Y; Wang S; Wu J; Wang Y
J Transl Med; 2023 Jul; 21(1):510. PubMed ID: 37507803
[TBL] [Abstract][Full Text] [Related]
2. Phytotherapy using blueberry leaf polyphenols to alleviate non-alcoholic fatty liver disease through improving mitochondrial function and oxidative defense.
Li Z; Zhang H; Li Y; Chen H; Wang C; Wong VKW; Jiang Z; Zhang W
Phytomedicine; 2020 Apr; 69():153209. PubMed ID: 32240928
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.
Lee K; Haddad A; Osme A; Kim C; Borzou A; Ilchenko S; Allende D; Dasarathy S; McCullough A; Sadygov RG; Kasumov T
Mol Cell Proteomics; 2018 Dec; 17(12):2371-2386. PubMed ID: 30171159
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial oxidative function in NAFLD: Friend or foe?
Shum M; Ngo J; Shirihai OS; Liesa M
Mol Metab; 2021 Aug; 50():101134. PubMed ID: 33276146
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease.
Ramanathan R; Ali AH; Ibdah JA
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806284
[TBL] [Abstract][Full Text] [Related]
6. The Alterations of Mitochondrial Function during NAFLD Progression-An Independent Effect of Mitochondrial ROS Production.
Simões ICM; Amorim R; Teixeira J; Karkucinska-Wieckowska A; Carvalho A; Pereira SP; Simões RF; Szymanska S; Dąbrowski M; Janikiewicz J; Dobrzyń A; Oliveira PJ; Potes Y; Wieckowski MR
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202179
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of non-alcoholic fatty liver disease by regulation of mitochondrial function with Chinese medicine].
Ma Q; Shi AH; Zhao X; Chen WL
Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(19):5113-5120. PubMed ID: 36472018
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
World J Gastroenterol; 2014 Oct; 20(39):14205-18. PubMed ID: 25339807
[TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor 3 is a target molecule linking hepatic steatosis to impaired glucose homeostasis.
Kim JY; Park KJ; Hwang JY; Kim GH; Lee D; Lee YJ; Song EH; Yoo MG; Kim BJ; Suh YH; Roh GS; Gao B; Kim W; Kim WH
J Hepatol; 2017 Aug; 67(2):349-359. PubMed ID: 28365312
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
Peng KY; Watt MJ; Rensen S; Greve JW; Huynh K; Jayawardana KS; Meikle PJ; Meex RCR
J Lipid Res; 2018 Oct; 59(10):1977-1986. PubMed ID: 30042157
[TBL] [Abstract][Full Text] [Related]
11. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.
Abdelmegeed MA; Ha SK; Choi Y; Akbar M; Song BJ
Curr Mol Pharmacol; 2017; 10(3):207-225. PubMed ID: 26278393
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD).
Zhao Y; Zhou Y; Wang D; Huang Z; Xiao X; Zheng Q; Li S; Long D; Feng L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139341
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
Fontes A; Alemany-Pagès M; Oliveira PJ; Ramalho-Santos J; Zischka H; Azul AM
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426291
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease.
Legaki AI; Moustakas II; Sikorska M; Papadopoulos G; Velliou RI; Chatzigeorgiou A
Curr Obes Rep; 2022 Sep; 11(3):126-143. PubMed ID: 35501558
[TBL] [Abstract][Full Text] [Related]
15. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
Xu L; Nagata N; Ota T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775341
[TBL] [Abstract][Full Text] [Related]
16. Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver.
Wang D; Ji DC; Yu CY; Wu DN; Qi L
World J Gastroenterol; 2023 Apr; 29(13):1982-1993. PubMed ID: 37155524
[TBL] [Abstract][Full Text] [Related]
17. Ablation of catalase promotes non-alcoholic fatty liver via oxidative stress and mitochondrial dysfunction in diet-induced obese mice.
Shin SK; Cho HW; Song SE; Bae JH; Im SS; Hwang I; Ha H; Song DK
Pflugers Arch; 2019 Jun; 471(6):829-843. PubMed ID: 30617744
[TBL] [Abstract][Full Text] [Related]
18. Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease.
Guo R; Liong EC; So KF; Fung ML; Tipoe GL
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):139-44. PubMed ID: 25865685
[TBL] [Abstract][Full Text] [Related]
19. Mechanism and regulation of mitophagy in nonalcoholic fatty liver disease (NAFLD): A mini-review.
Zhu L; Wu X; Liao R
Life Sci; 2023 Jan; 312():121162. PubMed ID: 36372213
[TBL] [Abstract][Full Text] [Related]
20. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis.
Wang L; Liu X; Nie J; Zhang J; Kimball SR; Zhang H; Zhang WJ; Jefferson LS; Cheng Z; Ji Q; Shi Y
Hepatology; 2015 Feb; 61(2):486-96. PubMed ID: 25203315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
